Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.446NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.76 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.398NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.163NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22077.4South Korea
P.3 (Theta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.277NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-211.894South Korea
AY.28 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.272NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.371NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.425NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.144NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.288NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.249NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.378NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.439NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.408NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.256NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.128NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.405NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.296NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.412NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.421NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.364NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.82NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JB.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used